NASDAQ:NVAX

Novavax Shares Gain 19% in Short Week
····

Novavax Shares Gain 19% in Short Week

Novavax shares closed Friday at $10.97, up 6.3%, capping a 19% gain since May 22 as the FDA told vaccine makers to target the XFG variant for 2026-27 COVID shots. Novavax and Sanofi are developing a protein-based vaccine, set to compete with Pfizer and Moderna’s mRNA shots. Novavax’s Q1 revenue fell 79% to $140 million, mostly from licensing. The company maintains its 2026 adjusted revenue outlook at $230–$270 million.
May 31, 2026

Stock Market Today

  • Australia Pet Food Market Report 2024: Growth, Pricing, and Key Players Analysis
    May 31, 2026, 4:44 PM EDT. The Australia pet food market shows significant growth potential, driven by segments defined by format, need state, and price tier. Leading brands and private labels differ in scale and channel strength. The report maps pricing and promotional impacts on demand, highlighting how price ladders and pack-price logic affect revenue. Supply chain factors including manufacturing and route-to-market strategies influence market performance. Forecasts extend to 2035, identifying white-space opportunities across channels and regions. This study aids brand owners, investors, and retailers seeking insight into category growth, competitive dynamics, and consumer behavior shaping the pet food sector.